
KKR Income Opportunities Fund is a close ended fixed income mutual fund launched by Kohlberg Kravis Roberts & Co. L.P. The fund is managed by KKR Asset Management LLC. It invests in fixed income markets and hedging markets across the globe. The fund primarily invests in first- and second-lien secured loans, unsecured loans and high yield corporate debt instruments. It employs fundamental analysis, with a focus on dynamic hedging strategies to create its portfolio. KKR Income Opportunities Fund was formed on March 17, 2011 and is domiciled in the United States.
Is KIO's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.

We review CEF market valuation and performance through the second week of October and highlight recent market action. CEF market discounts have widened to near 2-year highs, with mixed sector performance and only modest year-to-date gains. CCC credit spreads have surged 70% YTD, signaling higher default risk and underperformance for lower-quality loan CEFs like KIO.

KKR Income Opportunities Fund (NYSE: KIO - Get Free Report) was the recipient of a significant drop in short interest in September. As of September 30th, there was short interest totaling 56,787 shares, a drop of 75.2% from the September 15th total of 228,555 shares. Based on an average daily volume of 218,684 shares, the days-to-cover

NEW YORK--(BUSINESS WIRE)--KKR Income Opportunities Fund (the “Fund”) (NYSE: KIO) today announced its monthly distributions of $0.1215 per common share, payable on the dates below. Based on the Fund's current share price of $10.97 per share (as of market close on September 9, 2026), the distributions represent an annualized distribution rate of 13.29% (calculated by annualizing the distribution amount and dividing it by the current price). The monthly distribution schedule is as follows for the.

Encinitas, California--(Newsfile Corp. - August 19, 2026) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora") today announced that it has licensed the development and commercialization rights for KIO-301 in South Korea for ophthalmic indications to Chong Kun Dang Pharmaceutical Corporation (CKD). CKD, based in Seoul, is one of South Korea's leading pharmaceutical companies.

KKR Income Opportunities Fund (NYSE: KIO - Get Free Report)'s stock price crossed below its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $11.24 and traded as low as $11.20. KKR Income Opportunities Fund shares last traded at $11.2130, with a volume of 366,158 shares traded. KKR Income